Global Spinal Fusion Biologics Market Growth 2022-2028
- LP 4952155
- 107 Pages
- May 2022
- Medical Devices
The United States Spinal Fusion Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Spinal Fusion Biologics market, reaching US$ million by the year 2028. As for the Europe Spinal Fusion Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Spinal Fusion Biologics players cover Medtronic, J &J (DePuy Synthes), SeaSpine, and Xtant Medical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Spinal Fusion Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Spinal Fusion Biologics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Spinal Fusion Biologics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Spinal Fusion Biologics by Country/Region, 2017, 2022 & 2028
2.2 Spinal Fusion Biologics Segment by Type
2.2.1 Bone Graft
2.2.2 Bone Graft Substitute
2.2.3 Platelet Rich Plasma (PRP)
2.2.4 Other
2.3 Spinal Fusion Biologics Sales by Type
2.3.1 Global Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
2.3.2 Global Spinal Fusion Biologics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Spinal Fusion Biologics Sale Price by Type (2017-2022)
2.4 Spinal Fusion Biologics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Spinal Fusion Biologics Sales by Application
2.5.1 Global Spinal Fusion Biologics Sale Market Share by Application (2017-2022)
2.5.2 Global Spinal Fusion Biologics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Spinal Fusion Biologics Sale Price by Application (2017-2022)
3 Global Spinal Fusion Biologics by Company
3.1 Global Spinal Fusion Biologics Breakdown Data by Company
3.1.1 Global Spinal Fusion Biologics Annual Sales by Company (2020-2022)
3.1.2 Global Spinal Fusion Biologics Sales Market Share by Company (2020-2022)
3.2 Global Spinal Fusion Biologics Annual Revenue by Company (2020-2022)
3.2.1 Global Spinal Fusion Biologics Revenue by Company (2020-2022)
3.2.2 Global Spinal Fusion Biologics Revenue Market Share by Company (2020-2022)
3.3 Global Spinal Fusion Biologics Sale Price by Company
3.4 Key Manufacturers Spinal Fusion Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Spinal Fusion Biologics Product Location Distribution
3.4.2 Players Spinal Fusion Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Spinal Fusion Biologics by Geographic Region
4.1 World Historic Spinal Fusion Biologics Market Size by Geographic Region (2017-2022)
4.1.1 Global Spinal Fusion Biologics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Spinal Fusion Biologics Annual Revenue by Geographic Region
4.2 World Historic Spinal Fusion Biologics Market Size by Country/Region (2017-2022)
4.2.1 Global Spinal Fusion Biologics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Spinal Fusion Biologics Annual Revenue by Country/Region
4.3 Americas Spinal Fusion Biologics Sales Growth
4.4 APAC Spinal Fusion Biologics Sales Growth
4.5 Europe Spinal Fusion Biologics Sales Growth
4.6 Middle East & Africa Spinal Fusion Biologics Sales Growth
5 Americas
5.1 Americas Spinal Fusion Biologics Sales by Country
5.1.1 Americas Spinal Fusion Biologics Sales by Country (2017-2022)
5.1.2 Americas Spinal Fusion Biologics Revenue by Country (2017-2022)
5.2 Americas Spinal Fusion Biologics Sales by Type
5.3 Americas Spinal Fusion Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Spinal Fusion Biologics Sales by Region
6.1.1 APAC Spinal Fusion Biologics Sales by Region (2017-2022)
6.1.2 APAC Spinal Fusion Biologics Revenue by Region (2017-2022)
6.2 APAC Spinal Fusion Biologics Sales by Type
6.3 APAC Spinal Fusion Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Spinal Fusion Biologics by Country
7.1.1 Europe Spinal Fusion Biologics Sales by Country (2017-2022)
7.1.2 Europe Spinal Fusion Biologics Revenue by Country (2017-2022)
7.2 Europe Spinal Fusion Biologics Sales by Type
7.3 Europe Spinal Fusion Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Spinal Fusion Biologics by Country
8.1.1 Middle East & Africa Spinal Fusion Biologics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Spinal Fusion Biologics Revenue by Country (2017-2022)
8.2 Middle East & Africa Spinal Fusion Biologics Sales by Type
8.3 Middle East & Africa Spinal Fusion Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Spinal Fusion Biologics
10.3 Manufacturing Process Analysis of Spinal Fusion Biologics
10.4 Industry Chain Structure of Spinal Fusion Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Spinal Fusion Biologics Distributors
11.3 Spinal Fusion Biologics Customer
12 World Forecast Review for Spinal Fusion Biologics by Geographic Region
12.1 Global Spinal Fusion Biologics Market Size Forecast by Region
12.1.1 Global Spinal Fusion Biologics Forecast by Region (2023-2028)
12.1.2 Global Spinal Fusion Biologics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Spinal Fusion Biologics Forecast by Type
12.7 Global Spinal Fusion Biologics Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Spinal Fusion Biologics Product Offered
13.1.3 Medtronic Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 J &J (DePuy Synthes)
13.2.1 J &J (DePuy Synthes) Company Information
13.2.2 J &J (DePuy Synthes) Spinal Fusion Biologics Product Offered
13.2.3 J &J (DePuy Synthes) Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 J &J (DePuy Synthes) Main Business Overview
13.2.5 J &J (DePuy Synthes) Latest Developments
13.3 SeaSpine
13.3.1 SeaSpine Company Information
13.3.2 SeaSpine Spinal Fusion Biologics Product Offered
13.3.3 SeaSpine Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 SeaSpine Main Business Overview
13.3.5 SeaSpine Latest Developments
13.4 Xtant Medical
13.4.1 Xtant Medical Company Information
13.4.2 Xtant Medical Spinal Fusion Biologics Product Offered
13.4.3 Xtant Medical Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Xtant Medical Main Business Overview
13.4.5 Xtant Medical Latest Developments
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Information
13.5.2 Zimmer Biomet Spinal Fusion Biologics Product Offered
13.5.3 Zimmer Biomet Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zimmer Biomet Main Business Overview
13.5.5 Zimmer Biomet Latest Developments
13.6 Stryker
13.6.1 Stryker Company Information
13.6.2 Stryker Spinal Fusion Biologics Product Offered
13.6.3 Stryker Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Stryker Main Business Overview
13.6.5 Stryker Latest Developments
13.7 Straumann
13.7.1 Straumann Company Information
13.7.2 Straumann Spinal Fusion Biologics Product Offered
13.7.3 Straumann Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Straumann Main Business Overview
13.7.5 Straumann Latest Developments
13.8 Wright Medical Group
13.8.1 Wright Medical Group Company Information
13.8.2 Wright Medical Group Spinal Fusion Biologics Product Offered
13.8.3 Wright Medical Group Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Wright Medical Group Main Business Overview
13.8.5 Wright Medical Group Latest Developments
13.9 Hans Biomed
13.9.1 Hans Biomed Company Information
13.9.2 Hans Biomed Spinal Fusion Biologics Product Offered
13.9.3 Hans Biomed Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hans Biomed Main Business Overview
13.9.5 Hans Biomed Latest Developments
13.10 Arthrex
13.10.1 Arthrex Company Information
13.10.2 Arthrex Spinal Fusion Biologics Product Offered
13.10.3 Arthrex Spinal Fusion Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Arthrex Main Business Overview
13.10.5 Arthrex Latest Developments
14 Research Findings and Conclusion
Table 1. Spinal Fusion Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Spinal Fusion Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Bone Graft
Table 4. Major Players of Bone Graft Substitute
Table 5. Major Players of Platelet Rich Plasma (PRP)
Table 6. Major Players of Other
Table 7. Global Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 8. Global Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
Table 9. Global Spinal Fusion Biologics Revenue by Type (2017-2022) & ($ million)
Table 10. Global Spinal Fusion Biologics Revenue Market Share by Type (2017-2022)
Table 11. Global Spinal Fusion Biologics Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 13. Global Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Table 14. Global Spinal Fusion Biologics Revenue by Application (2017-2022)
Table 15. Global Spinal Fusion Biologics Revenue Market Share by Application (2017-2022)
Table 16. Global Spinal Fusion Biologics Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Spinal Fusion Biologics Sales by Company (2020-2022) & (Units)
Table 18. Global Spinal Fusion Biologics Sales Market Share by Company (2020-2022)
Table 19. Global Spinal Fusion Biologics Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Spinal Fusion Biologics Revenue Market Share by Company (2020-2022)
Table 21. Global Spinal Fusion Biologics Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Spinal Fusion Biologics Producing Area Distribution and Sales Area
Table 23. Players Spinal Fusion Biologics Products Offered
Table 24. Spinal Fusion Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Spinal Fusion Biologics Sales by Geographic Region (2017-2022) & (Units)
Table 28. Global Spinal Fusion Biologics Sales Market Share Geographic Region (2017-2022)
Table 29. Global Spinal Fusion Biologics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Spinal Fusion Biologics Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Spinal Fusion Biologics Sales by Country/Region (2017-2022) & (Units)
Table 32. Global Spinal Fusion Biologics Sales Market Share by Country/Region (2017-2022)
Table 33. Global Spinal Fusion Biologics Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Spinal Fusion Biologics Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 36. Americas Spinal Fusion Biologics Sales Market Share by Country (2017-2022)
Table 37. Americas Spinal Fusion Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Spinal Fusion Biologics Revenue Market Share by Country (2017-2022)
Table 39. Americas Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 40. Americas Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
Table 41. Americas Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 42. Americas Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Table 43. APAC Spinal Fusion Biologics Sales by Region (2017-2022) & (Units)
Table 44. APAC Spinal Fusion Biologics Sales Market Share by Region (2017-2022)
Table 45. APAC Spinal Fusion Biologics Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Spinal Fusion Biologics Revenue Market Share by Region (2017-2022)
Table 47. APAC Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 48. APAC Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
Table 49. APAC Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 50. APAC Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Table 51. Europe Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 52. Europe Spinal Fusion Biologics Sales Market Share by Country (2017-2022)
Table 53. Europe Spinal Fusion Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Spinal Fusion Biologics Revenue Market Share by Country (2017-2022)
Table 55. Europe Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 56. Europe Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
Table 57. Europe Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 58. Europe Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Spinal Fusion Biologics Sales by Country (2017-2022) & (Units)
Table 60. Middle East & Africa Spinal Fusion Biologics Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Spinal Fusion Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Spinal Fusion Biologics Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Spinal Fusion Biologics Sales by Type (2017-2022) & (Units)
Table 64. Middle East & Africa Spinal Fusion Biologics Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Spinal Fusion Biologics Sales by Application (2017-2022) & (Units)
Table 66. Middle East & Africa Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Spinal Fusion Biologics
Table 68. Key Market Challenges & Risks of Spinal Fusion Biologics
Table 69. Key Industry Trends of Spinal Fusion Biologics
Table 70. Spinal Fusion Biologics Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Spinal Fusion Biologics Distributors List
Table 73. Spinal Fusion Biologics Customer List
Table 74. Global Spinal Fusion Biologics Sales Forecast by Region (2023-2028) & (Units)
Table 75. Global Spinal Fusion Biologics Sales Market Forecast by Region
Table 76. Global Spinal Fusion Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Spinal Fusion Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Spinal Fusion Biologics Sales Forecast by Country (2023-2028) & (Units)
Table 79. Americas Spinal Fusion Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Spinal Fusion Biologics Sales Forecast by Region (2023-2028) & (Units)
Table 81. APAC Spinal Fusion Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Spinal Fusion Biologics Sales Forecast by Country (2023-2028) & (Units)
Table 83. Europe Spinal Fusion Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Spinal Fusion Biologics Sales Forecast by Country (2023-2028) & (Units)
Table 85. Middle East & Africa Spinal Fusion Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Spinal Fusion Biologics Sales Forecast by Type (2023-2028) & (Units)
Table 87. Global Spinal Fusion Biologics Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Spinal Fusion Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Spinal Fusion Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Spinal Fusion Biologics Sales Forecast by Application (2023-2028) & (Units)
Table 91. Global Spinal Fusion Biologics Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Spinal Fusion Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Spinal Fusion Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 94. Medtronic Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. Medtronic Spinal Fusion Biologics Product Offered
Table 96. Medtronic Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Medtronic Main Business
Table 98. Medtronic Latest Developments
Table 99. J &J (DePuy Synthes) Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. J &J (DePuy Synthes) Spinal Fusion Biologics Product Offered
Table 101. J &J (DePuy Synthes) Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. J &J (DePuy Synthes) Main Business
Table 103. J &J (DePuy Synthes) Latest Developments
Table 104. SeaSpine Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. SeaSpine Spinal Fusion Biologics Product Offered
Table 106. SeaSpine Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. SeaSpine Main Business
Table 108. SeaSpine Latest Developments
Table 109. Xtant Medical Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Xtant Medical Spinal Fusion Biologics Product Offered
Table 111. Xtant Medical Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Xtant Medical Main Business
Table 113. Xtant Medical Latest Developments
Table 114. Zimmer Biomet Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Zimmer Biomet Spinal Fusion Biologics Product Offered
Table 116. Zimmer Biomet Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Zimmer Biomet Main Business
Table 118. Zimmer Biomet Latest Developments
Table 119. Stryker Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Stryker Spinal Fusion Biologics Product Offered
Table 121. Stryker Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Stryker Main Business
Table 123. Stryker Latest Developments
Table 124. Straumann Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Straumann Spinal Fusion Biologics Product Offered
Table 126. Straumann Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Straumann Main Business
Table 128. Straumann Latest Developments
Table 129. Wright Medical Group Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 130. Wright Medical Group Spinal Fusion Biologics Product Offered
Table 131. Wright Medical Group Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Wright Medical Group Main Business
Table 133. Wright Medical Group Latest Developments
Table 134. Hans Biomed Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 135. Hans Biomed Spinal Fusion Biologics Product Offered
Table 136. Hans Biomed Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Hans Biomed Main Business
Table 138. Hans Biomed Latest Developments
Table 139. Arthrex Basic Information, Spinal Fusion Biologics Manufacturing Base, Sales Area and Its Competitors
Table 140. Arthrex Spinal Fusion Biologics Product Offered
Table 141. Arthrex Spinal Fusion Biologics Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Arthrex Main Business
Table 143. Arthrex Latest Developments
List of Figures
Figure 1. Picture of Spinal Fusion Biologics
Figure 2. Spinal Fusion Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Spinal Fusion Biologics Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Spinal Fusion Biologics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Spinal Fusion Biologics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Bone Graft
Figure 10. Product Picture of Bone Graft Substitute
Figure 11. Product Picture of Platelet Rich Plasma (PRP)
Figure 12. Product Picture of Other
Figure 13. Global Spinal Fusion Biologics Sales Market Share by Type in 2021
Figure 14. Global Spinal Fusion Biologics Revenue Market Share by Type (2017-2022)
Figure 15. Spinal Fusion Biologics Consumed in Hospital
Figure 16. Global Spinal Fusion Biologics Market: Hospital (2017-2022) & (Units)
Figure 17. Spinal Fusion Biologics Consumed in Clinic
Figure 18. Global Spinal Fusion Biologics Market: Clinic (2017-2022) & (Units)
Figure 19. Spinal Fusion Biologics Consumed in Other
Figure 20. Global Spinal Fusion Biologics Market: Other (2017-2022) & (Units)
Figure 21. Global Spinal Fusion Biologics Sales Market Share by Application (2017-2022)
Figure 22. Global Spinal Fusion Biologics Revenue Market Share by Application in 2021
Figure 23. Spinal Fusion Biologics Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Spinal Fusion Biologics Revenue Market Share by Company in 2021
Figure 25. Global Spinal Fusion Biologics Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Spinal Fusion Biologics Revenue Market Share by Geographic Region in 2021
Figure 27. Global Spinal Fusion Biologics Sales Market Share by Region (2017-2022)
Figure 28. Global Spinal Fusion Biologics Revenue Market Share by Country/Region in 2021
Figure 29. Americas Spinal Fusion Biologics Sales 2017-2022 (Units)
Figure 30. Americas Spinal Fusion Biologics Revenue 2017-2022 ($ Millions)
Figure 31. APAC Spinal Fusion Biologics Sales 2017-2022 (Units)
Figure 32. APAC Spinal Fusion Biologics Revenue 2017-2022 ($ Millions)
Figure 33. Europe Spinal Fusion Biologics Sales 2017-2022 (Units)
Figure 34. Europe Spinal Fusion Biologics Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Spinal Fusion Biologics Sales 2017-2022 (Units)
Figure 36. Middle East & Africa Spinal Fusion Biologics Revenue 2017-2022 ($ Millions)
Figure 37. Americas Spinal Fusion Biologics Sales Market Share by Country in 2021
Figure 38. Americas Spinal Fusion Biologics Revenue Market Share by Country in 2021
Figure 39. United States Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Spinal Fusion Biologics Sales Market Share by Region in 2021
Figure 44. APAC Spinal Fusion Biologics Revenue Market Share by Regions in 2021
Figure 45. China Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Spinal Fusion Biologics Sales Market Share by Country in 2021
Figure 52. Europe Spinal Fusion Biologics Revenue Market Share by Country in 2021
Figure 53. Germany Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Spinal Fusion Biologics Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Spinal Fusion Biologics Revenue Market Share by Country in 2021
Figure 60. Egypt Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Spinal Fusion Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Spinal Fusion Biologics in 2021
Figure 66. Manufacturing Process Analysis of Spinal Fusion Biologics
Figure 67. Industry Chain Structure of Spinal Fusion Biologics
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
